Biomarker study for systemic histiocytosis
Part of Blood & lymphatic clinical trials.
This trial aims to find biological markers in people with systemic histiocytosis by analyzing blood or tissue samples. It may help better understand and manage the disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are being treated for systemic histiocytosis at the Internal Medicine Department 2 of Pitié-Salpêtrière Hospital.
- You agree to participate in the study (no written consent needed, just non-opposition).
- You are not pregnant or breastfeeding.
- You have French social security or are not on State Medical Aid (AME).
- You are not in prison or under legal guardianship.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study helps doctors better understand your cancer by doing tumor/cancer profiling as part of research. If you qualify, your participation may help improve how cancers are studied and matched with future treatments.
This study is looking for adults with Langerhans cell histiocytosis (LCH) and also for adults with certain lung conditions (like cystic lung disease or emphysema) or healthy smokers to act as controls. The goal is to find biomarkers (signs in the body) that can help doctors diagnose LCH, predict how it will progress, and see how well treatment is working.
This study creates a bank of leftover blood and other samples from patients at two French hospitals. It helps researchers test new, faster ways to diagnose diseases.
This study looks at blood “biomarkers,” or measurable body signals, in people with autoimmune diseases, vasculitis, or autoinflammatory conditions. The goal is to better understand these illnesses and how they relate to disease activity.
This study looks at people with histiocytic disorders, which are rare conditions where certain immune cells grow too much. It aims to learn more about these disorders to improve diagnosis and treatment.
This study collects and stores tumor and blood samples from children and young adults with cancer, blood disorders, or immune conditions. The samples are used to better understand these diseases and could help future treatments.
Hear when a new Systemic Histiocytosis (Disorder) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.